株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ウシ血清アルブミン (BSA) の世界市場 - 2025年までの予測:低温エタノール分画法・イオン交換クロマトグラフィー法・ヒートショック分画法・膜ろ過法

Bovine Serum Albumin Market by Form (Dry, Liquid), Grade (Technical-& Diagnostic-Grade, Research/Reagent-Grade, Food Grade), End User (Life Sciences Industry, Feed Industry, Food Industry, Research Institutes), and Region - Global Forecast to 2025

発行 MarketsandMarkets 商品コード 906780
出版日 ページ情報 英文 154 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.52円で換算しております。
Back to Top
ウシ血清アルブミン (BSA) の世界市場 - 2025年までの予測:低温エタノール分画法・イオン交換クロマトグラフィー法・ヒートショック分画法・膜ろ過法 Bovine Serum Albumin Market by Form (Dry, Liquid), Grade (Technical-& Diagnostic-Grade, Research/Reagent-Grade, Food Grade), End User (Life Sciences Industry, Feed Industry, Food Industry, Research Institutes), and Region - Global Forecast to 2025
出版日: 2019年08月13日 ページ情報: 英文 154 Pages
概要

世界のウシ血清アルブミン (BSA) 市場規模は、2019年の2億5,500万米ドルから2025年までに3億400万米ドルへ達すると予測され、この間は3.0%のCAGR (年間複合成長率) が見込まれています。タンパク質スタンダードとしてのBSAの低価格および安定した性質、ならびに家畜頭数の増加は血液由来製品の需要拡大をもたらし、同市場の成長を促進しています。

当レポートでは、世界のウシ血清アルブミン (BSA) 市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • ウシ血清アルブミン (BSA) 市場における魅力的な成長機会
  • ウシ血清アルブミン (BSA) 市場:地域別
  • ウシ血清アルブミン (BSA) 市場:エンドユーザー別
  • アジア太平洋のウシ血清アルブミン (BSA) 市場:グレード & 国/地域別
  • ウシ血清アルブミン (BSA) 市場:主要な2次地域市場別

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 産業動向
  • ポーターのファイブフォース分析

第6章 規制の枠組み

  • イントロダクション

第7章 ウシ血清アルブミン (BSA) 市場:調合法別

  • イントロダクション
  • 低温エタノール分画法
  • イオン交換クロマトグラフィー法
  • ヒートショック分画法
  • 膜ろ過法

第8章 ウシ血清アルブミン (BSA) 市場:グレード別

  • イントロダクション
  • 技術 & 診断グレード
  • 試薬 / 研究グレード
  • 食品グレード

第9章 ウシ血清アルブミン (BSA) 市場:形態別

  • イントロダクション
  • 乾燥型
  • 液体型

第10章 ウシ血清アルブミン (BSA) 市場:エンドユーザー別

  • イントロダクション
  • ライフサイエンス産業
  • 研究機関
  • 食品産業
  • 飼料産業

第11章 ウシ血清アルブミン (BSA) 市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他

第12章 競合情勢

  • 概要
  • 競合リーダーシップマッピング
  • 製品ポートフォリオの強み
  • 事業戦略の長所
  • 主要企業のランキング
  • 競合シナリオ

第13章 企業プロファイル

  • THERMO FISHER SCIENTIFIC INC.
  • BIO-RAD LABORATORIES, INC.
  • MERCK KGAA
  • ITOHAM YONEKYU HOLDINGS INC.
  • PROLIANT BIOLOGICALS
  • KRAEBER & CO GMBH
  • ROCKLAND IMMUNOCHEMICALS INC.
  • ROCKY MOUNTAIN BIOLOGICALS
  • BELHEALTH INVESTMENT PARTNERS, LLC
  • BIO-TECHNE CORPORATION
  • PROSPEC-TANY TECHNOGENE LTD.
  • LGC GROUP
  • PROMEGA CORPORATION
  • BIOLOGICAL INDUSTRIES
  • SERION GMBH

第14章 付録

図表

LIST OF TABLES

  • TABLE 1: USD EXCHANGE RATES CONSIDERED, 2014-2018
  • TABLE 2: DISTRIBUTION OF PLASMA PROTEINS IN THE COHN FRACTIONATION SYSTEM
  • TABLE 3: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD MILLION)
  • TABLE 4: TECHNICAL-& DIAGNOSTIC-GRADE BOVINE SERUM ALBUMIN MARKET SIZE, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 5: REAGENT-/RESEARCH-GRADE BOVINE SERUM ALBUMIN MARKET SIZE, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 6: BOVINE SERUM ALBUMIN-BASED PRODUCTS IN THE FOOD INDUSTRY
  • TABLE 7: FOOD-GRADE BOVINE SERUM ALBUMIN MARKET SIZE, BY REGION, 2017-2025 (USD THOUSAND)
  • TABLE 8: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 9: DRY BOVINE SERUM ALBUMIN MARKET SIZE, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 10: LIQUID BOVINE SERUM ALBUMIN MARKET SIZE, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 11: BOVINE SERUM ALBUMIN MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  • TABLE 12: BOVINE SERUM ALBUMIN MARKET SIZE IN LIFE SCIENCES INDUSTRY, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 13: BOVINE SERUM ALBUMIN MARKET SIZE IN DRUG DELIVERY, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 14: BOVINE SERUM ALBUMIN MARKET SIZE IN CELL CULTURE, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 15: BOVINE SERUM ALBUMIN MARKET SIZE IN DIAGNOSTICS, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 16: BOVINE SERUM ALBUMIN MARKET SIZE IN RESEARCH INSTITUTES, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 17: FOOD INDUSTRY: BOVINE SERUM ALBUMIN MARKET SIZE, BY REGION, 2017-2025 (USD THOUSAND)
  • TABLE 18: BOVINE SERUM ALBUMIN MARKET SIZE IN FEED INDUSTRY, BY REGION, 2017-2025 (USD THOUSANDS)
  • TABLE 19: BOVINE SERUM ALBUMIN MARKET SIZE, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 20: BOVINE MEAT PRODUCTION IN SELECTED COUNTRIES, 2017 ('000 TONNE)
  • TABLE 21: NORTH AMERICA: BOVINE SERUM ALBUMIN MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 22: NORTH AMERICA: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD BILLION)
  • TABLE 23: NORTH AMERICA: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD MILLION)
  • TABLE 24: NORTH AMERICA: BOVINE SERUM ALBUMIN MARKET SIZE, BY END USER, 2017-2025 (USD THOUSAND)
  • TABLE 25: NORTH AMERICA: BOVINE SERUM ALBUMIN MARKET SIZE IN LIFE SCIENCES INDUSTRY, BY END USE, 2017-2025 (USD THOUSAND)
  • TABLE 26: US: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 27: US: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD MILLION)
  • TABLE 28: CANADA: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 29: CANADA: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 30: MEXICO: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD THOUSAND)
  • TABLE 31: MEXICO: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 32: EUROPE: BOVINE SERUM ALBUMIN MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  • TABLE 33: EUROPE: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 34: EUROPE: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD MILLION)
  • TABLE 35: EUROPE: BOVINE SERUM ALBUMIN MARKET SIZE, BY END USER, 2017-2025 (USD THOUSAND)
  • TABLE 36: EUROPE: BOVINE SERUM ALBUMIN MARKET SIZE IN LIFE SCIENCES INDUSTRY, BY END USE, 2017-2025 (USD MILLION)
  • TABLE 37: GERMANY: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 38: GERMANY : BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 39: UK: MEAT CONSUMPTION, BY TYPE, 2014-2017
  • TABLE 40: UK: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 41: UK : BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 42: FRANCE: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 43: FRANCE : BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 44: SPAIN: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD THOUSAND)
  • TABLE 45: SPAIN: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 46: RUSSIA: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD THOUSAND)
  • TABLE 47: RUSSIA : BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 48: REST OF EUROPE: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 49: REST OF EUROPE : BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 50: ASIA PACIFIC: BOVINE SERUM ALBUMIN MARKET SIZE, BY COUNTRY/REGION, 2017-2025 (USD MILLION)
  • TABLE 51: ASIA PACIFIC: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD MILLION)
  • TABLE 52: ASIA PACIFIC: BOVINE SERUM ALBUMIN MARKET SIZE, BY END USER, 2017-2025 (USD THOUSAND)
  • TABLE 53: ASIA PACIFIC: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 54: CHINA: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 55: CHINA: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD MILLION)
  • TABLE 56: INDIA: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD THOUSAND)
  • TABLE 57: INDIA: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 58: JAPAN: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD THOUSAND)
  • TABLE 59: JAPAN: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 60: AUSTRALIA & NEW ZEALAND: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD THOUSAND)
  • TABLE 61: AUSTRALIA & NEW ZEALAND: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 62: REST OF ASIA PACIFIC: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD THOUSAND)
  • TABLE 63: REST OF ASIA PACIFIC: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 64: ROW: BOVINE SERUM ALBUMIN MARKET SIZE, BY REGION, 2017-2025 (USD MILLION)
  • TABLE 65: ROW: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 66: ROW: BOVINE SERUM ALBUMIN MARKET SIZE, BY END USER, 2017-2025 (USD THOUSAND)
  • TABLE 67: ROW: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
  • TABLE 68: SOUTH AMERICA: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD THOUSAND)
  • TABLE 69: SOUTH AMERICA: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 70: MIDDLE EAST & AFRICA: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2017-2025 (USD THOUSAND)
  • TABLE 71: MIDDLE EAST & AFRICA: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2017-2025 (USD THOUSAND)
  • TABLE 72: NEW PRODUCT LAUNCHES 2017-2019
  • TABLE 73: EXPANSIONS & INVESTMENTS 2015-2018
  • TABLE 74: MERGERS & ACQUISITIONS, 2014-2018

LIST OF FIGURES

  • FIGURE 1: BOVINE SERUM ALBUMIN MARKET SEGMENTATION
  • FIGURE 2: REGIONAL SEGMENTATION
  • FIGURE 3: BOVINE SERUM ALBUMIN MARKET: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 5: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: MARKET SIZE ESTIMATION METHODOLOGY: SPECIFIC METHODOLOGY
  • FIGURE 8: DATA TRIANGULATION
  • FIGURE 9: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2019 VS. 2025 (USD MILLION)
  • FIGURE 10: BOVINE SERUM ALBUMIN MARKET SIZE, BY END USER, 2019 VS. 2025 (USD MILLION)
  • FIGURE 11: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2019 VS. 2025 (USD MILLION)
  • FIGURE 12: ASIA PACIFIC TO GROW AT THE HIGHEST CAGR IN THE BOVINE SERUM ALBUMIN MARKET FROM 2019 TO 2025
  • FIGURE 13: BOVINE SERUM ALBUMIN MARKET SHARE AND GROWTH (VALUE), BY REGION
  • FIGURE 14: GROWTH IN APPLICATION IN THE FOOD AND PHARMACEUTICAL INDUSTRIES OFFER ATTRACTIVE OPPORTUNITIES IN THE BOVINE SERUM ALBUMIN MARKET
  • FIGURE 15: NORTH AMERICA IS TO DOMINATE THE BOVINE SERUM ALBUMIN MARKET IN 2019 AND 2025
  • FIGURE 16: THE LIFE SCIENCES INDUSTRY IS SET TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: TECHNICAL- & DIAGNOSTIC-GRADE TO DOMINATE THE MARKET IN 2018
  • FIGURE 18: CHINA IS PROJECTED TO BE THE FASTEST-GROWING INDIVIDUAL MARKET FOR BOVINE SERUM ALBUMIN BETWEEN 2019 AND 2025
  • FIGURE 19: BOVINE SERUM EXTRACTION PROCESS
  • FIGURE 20: WIDENING SCOPE FOR APPLICATIONS IN MULTIFARIOUS INDUSTRIES DRIVING THE GROWTH OF THE BOVINE SERUM ALBUMIN MARKET
  • FIGURE 21: GLOBAL BOVINE MEAT PRODUCTION AND TRADE, 2015-2017 (IN MILLION TONNES)
  • FIGURE 22: CLASSIFICATION OF ANIMAL BY-PRODUCTS
  • FIGURE 23: BOVINE SERUM ALBUMIN MARKET: SUPPLY CHAIN
  • FIGURE 24: BOVINE SERUM EXTRACTION THROUGH COLD ETHANOL PROCESS
  • FIGURE 25: EXTRACTION OF ALBUMIN THROUGH ION EXCHANGE CHROMATOGRAPHY
  • FIGURE 26: BOVINE SERUM EXTRACTION THROUGH HEAT SHOCK FRACTIONATION
  • FIGURE 27: BOVINE SERUM ALBUMIN MARKET SIZE, BY GRADE, 2019 VS. 2025 (USD MILLION)
  • FIGURE 28: TECHNICAL- & DIAGNOSTIC-GRADE BOVINE SERUM ALBUMIN MARKET SIZE, BY REGION, 2019 VS. 2025 (USD MILLION)
  • FIGURE 29: BOVINE SERUM ALBUMIN MARKET SIZE, BY FORM, 2019 VS. 2025 (USD MILLION)
  • FIGURE 30: DRY FORM BOVINE SERUM ALBUMIN MARKET, 2019 VS 2025 (USD MILLION)
  • FIGURE 31: BOVINE SERUM ALBUMIN MARKET SIZE, BY END USER, 2019 VS. 2025 (USD MILLION)
  • FIGURE 32: BOVINE SERUM ALBUMIN MARKET SIZE IN LIFE SCIENCES INDUSTRY, BY REGION, 2019 VS. 2025 (USD MILLION)
  • FIGURE 33: GLOBAL FEED PRODUCTION, BY TARGET ANIMAL (MILLION METRIC TONS)
  • FIGURE 34: POULTRY FEED PRODUCTION, BY REGION, 2018 (MILLION METRIC TON)
  • FIGURE 35: AQUAFEED PRODUCTION, BY REGION, 2018 (MILLION METRIC TON)
  • FIGURE 36: PORCINE FEED PRODUCTION, BY REGION, 2018 (MILLION METRIC TON)
  • FIGURE 37: PET FOOD PRODUCTION, BY REGION, 2018 (MILLION METRIC TON)
  • FIGURE 38: US ACCOUNTED FOR THE LARGEST MARKET SHARE IN THE BOVINE SERUM ALBUMIN MARKET DURING THE FORECAST PERIOD
  • FIGURE 39: NORTH AMERICA: BOVINE SERUM ALBUMIN MARKET SNAPSHOT
  • FIGURE 40: US: MARKET SHARES OF TYPES OF MEAT PROCESSED, 2017
  • FIGURE 41: EUROPEAN UNION: BOVINE MEAT PRODUCTION SHARE, BY KEY COUNTRY, 2017
  • FIGURE 42: EUROPE: BOVINE SERUM ALBUMIN MARKET SNAPSHOT, 2018
  • FIGURE 43: GERMANY: FOOD & BEVERAGE INDUSTRY, BY SEGMENT, 2017
  • FIGURE 44: UK: CATTLE AND CALF PRODUCTION ON AGRICULTURAL LANDHOLDINGS, 2013-2017 (THOUSAND)
  • FIGURE 45: UK: MONTHLY LIVESTOCK SLAUGHTERED, 2019 ('000 HEAD)
  • FIGURE 46: TURNOVER OF FRENCH FOOD PROCESSING COMPANIES, 2017 (USD MILLION)
  • FIGURE 47: MAJOR FOOD PRODUCTS CONSUMED IN SPAIN, 2015
  • FIGURE 48: RUSSIA: ANNUAL PHARMACEUTICAL SALES, 2015-2017 (USD MILLION)
  • FIGURE 49: ASIA PACIFIC: BOVINE SERUM ALBUMIN MARKET SNAPSHOT, 2018
  • FIGURE 50: GLOBAL MILK PRODUCTION SHARE, BY REGION, 2018
  • FIGURE 51: CHEESE EXPORT OF ARGENTINA, 2018 (TONNE)
  • FIGURE 52: FEED PRODUCTION SHARE, BY REGION, 2018 (MILLION TONNE)
  • FIGURE 53: FEED PRODUCTION SHARE, BY TARGET LIVESTOCK TYPE, 2018
  • FIGURE 54: GROWTH IN FEED PRODUCTION, BY REGION, 2018
  • FIGURE 55: KEY DEVELOPMENTS OF THE LEADING PLAYERS IN THE BOVINE SERUM ALBUMIN MARKET, 2014-2019
  • FIGURE 56: BOVINE SERUM ALBUMIN MARKET COMPETITIVE LEADERSHIP MAPPING, 2018
  • FIGURE 57: MERCK KGAA LED THE BOVINE SERUM ALBUMIN MARKET IN, 2018
  • FIGURE 58: MARKET EVALUATION FRAMEWORK, 2016-2018
  • FIGURE 59: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 60: THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
  • FIGURE 61: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 62: BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
  • FIGURE 63: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 64: MERCK KGAA: SWOT ANALYSIS
  • FIGURE 65: ITOHAM YONEKYU HOLDINGS INC.: COMPANY SNAPSHOT
  • FIGURE 66: ITOHAM YONEKYU HOLDINGS INC.: SWOT ANALYSIS
  • FIGURE 67: PROLIANT BIOLOGICALS.: SWOT ANALYSIS
  • FIGURE 68: BIO-TECHNE CORPORATION.: COMPANY SNAPSHOT
  • FIGURE 69: LGC GROUP.: COMPANY SNAPSHOT
目次
Product Code: FB 7292

"The bovine serum albumin market is projected to grow at a CAGR of 3.0% from 2019 to 2025."

The global bovine serum albumin market is estimated to be valued at USD 255 million in 2019 and is projected to reach USD 304 million by 2025, recording a CAGR of 3.0%. Factors such as the low cost and stable nature of BSA as a protein standard and the increasing livestock population leading to a growing demand for blood-based products are driving the growth of this market.

The scope for the use of BSA as a dietary protein is opening new avenues for the application of BSA.

It has been established that BSA is a dietary whey protein that has anti-obesity effects. The intake of BSA as a part of low-fat diets prevents weight gain. Since obesity is a growing problem, the manufacturers are looking at cost-effective solutions for the production of dietary supplements. The cost of raw material for the production of BSA is very low due to which it has the potential to be used as a dietary supplement.

The technical- & diagnostic-grade segment to witness the fastest growth during the forecast period.

The technical- & diagnostic-grade is projected to witness fast growth due to its widespread application in areas such as cell culture and immunoassay preparation. The technical- & diagnostic-grade of BSA is most recommended for biotechnology applications such as immunodetections as a blocking and saturating agent. Most products that belong to this grade are used in cell culture applications.

Germany, in the European market, is estimated to account for the largest market share due to the growing in-vitro diagnostics industry.

In 2019, Germany is estimated to hold the largest market share due to the growing in-vitro diagnostics market in the country. Most of the diagnostic companies who operate in this industry generate their revenue through reagents. BSA is a reagent that finds use in immunochemistry, hematology, microbiology, immunology, and clinical chemistry. Some of the factors driving the market for BSA are the increase in the cases of chronic illness within the German population and growth in demand for personalized medicines.

Break-up of Primaries:

  • By Company Type: Tier 1 - 41%, Tier 2 - 35%, and Tier 3 - 24%
  • By Designation: C-level - 42%, D-level - 37%, and Others* - 21%
  • By Region: North America - 40%, Europe - 30%, Asia Pacific - 20%, Rest of the World (RoW)** - 10%

Others include sales managers, marketing managers, and product managers.

*RoW includes South America and the Middle East & Africa.

Leading players profiled in this report:

  • Thermo Fisher Scientific (US)
  • Bio-Rad Laboratories, Inc (US)
  • Merck KGAA (Germany)
  • Itoham Yonekyu Holdings Inc (Japan)
  • Proliant Biologicals (US)
  • Kraeber & Co Gmbh (Germany)
  • Rockland Immunochemicals Inc (US)
  • Rocky mountain biologicals (US),
  • BelHealth investment partners
  • LLC (US), Bio-Techne Corporation (US)
  • Prospec-Tany Technogene Ltd (Israel)
  • LGC Group (UK)
  • Promega Corporation (US)
  • Biological Industries (Israel)
  • Serion GmbH (Germany)

Research Coverage:

This report segments the bovine serum albumin market on the basis of form, grade, end user, method of preparation, and region. In terms of insights, this research report focuses on various levels of analyses-competitive landscape, end-use analysis, and company profiles-which together comprise and discuss the basic views on the emerging & high-growth segments of the global bovine serum albumin market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.

Reasons to Buy the Report:

  • To get a comprehensive overview of the bovine serum albumin market
  • To gain wide-ranging information about the top players in this industry, their product portfolios, and the key strategies adopted by them
  • To gain insights about the major countries/regions in which the bovine serum albumin market is flourishing

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 PERIODIZATION CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Breakdown of Primaries
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS & LIMITATIONS
    • 2.4.1 ASSUMPTIONS
    • 2.4.2 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE GROWTH OPPORTUNITIES IN THE BOVINE SERUM ALBUMIN MARKET
  • 4.2 BOVINE SERUM ALBUMIN MARKET, BY REGION
  • 4.3 BOVINE SERUM ALBUMIN MARKET, BY END USER
  • 4.4 ASIA PACIFIC: BOVINE SERUM ALBUMIN MARKET, BY GRADE & COUNTRY/REGION
  • 4.5 BOVINE SERUM ALBUMIN MARKET, BY KEY SUBREGIONAL MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Inexpensive and stable nature of bovine serum albumin as a protein standard
      • 5.2.1.2 Growth of the livestock industry and consequent demand generation for blood-based products
      • 5.2.1.3 Rise in application in the food & pharmaceutical industries
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Rise in demand for animal-free albumin products
      • 5.2.2.2 Growth in appeal to replace fetal bovine serum and its components in cell culture applications
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Scope for use as a dietary protein for fat reduction
      • 5.2.3.2 Usage in the biodegradable and edible food packaging industry
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Existence of alternatives in the diagnostic and pharmaceutical industries
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 SUPPLY CHAIN ANALYSIS
  • 5.4 PORTER'S FIVE FORCE ANALYSIS
    • 5.4.1 THREAT OF NEW ENTRANTS
    • 5.4.2 THREAT OF SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF BUYERS
    • 5.4.4 BARGAINING POWER OF SUPPLIERS
    • 5.4.5 INTENSITY OF RIVALRY

6 REGULATORY FRAMEWORK

  • 6.1 INTRODUCTION
    • 6.1.1 EXPORT TO VIETNAM: REQUIREMENT FOR EXPORT CERTIFICATION OF BOVINE BLOOD OR BLOOD PRODUCTS (SLAUGHTER COLLECTION)
    • 6.1.2 EXPORT TO VIETNAM: REQUIREMENT FOR EXPORT CERTIFICATION FOR FETAL BOVINE SERUM
    • 6.1.3 EXPORT TO TAIWAN: REQUIREMENT FOR EXPORT CERTIFICATION OF BOVINE SERUM ALBUMIN OR CULTURE MEDIA CONTAINING BSA
    • 6.1.4 EXPORT TO CANADA: REQUIREMENT FOR EXPORT CERTIFICATION OF BOVINE SERUM ALBUMIN FOR LABORATORY/TECHNICAL USE
    • 6.1.5 BOVINE SERUM ALBUMIN AS AN INDICATOR IN THE PRODUCTION OF VACCINES
    • 6.1.6 PORCINE BLOOD PRODUCTS FOR USE IN ANIMAL FEED

7 BOVINE SERUM ALBUMIN MARKET, BY METHOD OF PREPARATION

  • 7.1 INTRODUCTION
  • 7.2 COLD ETHANOL FRACTIONATION
    • 7.2.1 THE COST-EFFECTIVENESS AND SUITABILITY IN LARGE-SCALE PRODUCTION DRIVES THE DEMAND FOR COLD ETHANOL PROCESSED BSA
  • 7.3 ION EXCHANGE CHROMATOGRAPHY
    • 7.3.1 THE HIGH EFFICIENCY IN SEPARATION MAKES ION EXCHANGE CHROMATOGRAPHY A PREFERRED METHOD FOR PREPARATION OF BSA
  • 7.4 HEAT SHOCK FRACTIONATION
    • 7.4.1 THE HIGHLY PURIFIED BSA DERIVED THROUGH THIS METHOD HAS LED TO INCREASED DEMAND FROM DIAGNOSTICS AND RESEARCH INSTITUTES
  • 7.5 MEMBRANE FILTRATION
    • 7.5.1 THE HIGH ENERGY EFFICIENCY OF THE MEMBRANE FILTRATION METHOD HAS INCREASED ITS DEMAND IN THE FOOD INDUSTRY

8 BOVINE SERUM ALBUMIN MARKET, BY GRADE

  • 8.1 INTRODUCTION
  • 8.2 TECHNICAL- & DIAGNOSTIC-GRADE
    • 8.2.1 SOLUBILITY AND EASE OF FILTRATION MAKE THE DIAGNOSTIC GRADE OF BSA POPULAR IN BIOTECHNOLOGICAL APPLICATIONS
  • 8.1 REAGENT- /RESEARCH-GRADE
    • 8.1.1 THE MARKET FOR REAGENT-GRADE BSA IS TO GROW DUE TO INCREASING DEMAND FOR VACCINES FROM HIGH-INCOME COUNTRIES
  • 8.2 FOOD-GRADE
    • 8.2.1 THE HIGH DEMAND FOR BAKERY & CONFECTIONERY PRODUCTS IS DRIVING THE DEMAND FOR FOOD-GRADE BSA

9 BOVINE SERUM ALBUMIN MARKET, BY FORM

  • 9.1 INTRODUCTION
  • 9.2 DRY FORM
    • 9.2.1 THE DRY FORM OF BOVINE SERUM ALBUMIN IS LARGELY USED BECAUSE OF ITS LONGER SHELF LIFE
  • 9.3 LIQUID FORM
    • 9.3.1 THE LIQUID FORM OF BSA IS MOSTLY USED IN THE RESEARCH-BASED PHARMACEUTICAL INDUSTRY

10 BOVINE SERUM ALBUMIN MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 LIFE SCIENCES INDUSTRY
    • 10.2.1 RISE IN PREVALENCE OF CHRONIC ILLNESSES TO INCREASE THE SCOPE OF BSA IN THE LIFE SCIENCES INDUSTRY
    • 10.2.2 DRUG DELIVERY
    • 10.2.3 CELL CULTURE
    • 10.2.4 DIAGNOSTICS
  • 10.3 RESEARCH INSTITUTES
    • 10.3.1 RESEARCH CONDUCTED BY VARIOUS INSTITUTES FOR DISCOVERING MORE APPLICATIONS FOR BOVINE SERUM ALBUMIN
  • 10.4 FOOD INDUSTRY
    • 10.4.1 THE EMULSIFYING AND FOAMING PROPERTIES OF BLOOD PLASMA CREATE OPPORTUNITIES FOR BLOOD PROTEINS IN THE FOOD INDUSTRY
  • 10.5 FEED INDUSTRY
    • 10.5.1 INCREASE IN OPPORTUNITIES FOR BIOACTIVE INGREDIENTS IN THE FEED INDUSTRY DRIVE MARKET GROWTH
    • 10.5.2 POULTRY FEED
    • 10.5.3 AQUAFEED
    • 10.5.4 PORCINE FEED
    • 10.5.5 PET FOOD

11 BOVINE SERUM ALBUMIN MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 The dynamic meat processing industry is driving growth in the US market
    • 11.2.2 CANADA
      • 11.2.2.1 High demand for red meat and its products is set to drive the growth of the BSA market in Canada
    • 11.2.3 MEXICO
      • 11.2.3.1 Reduction in budgetary allocation for the livestock sector to impact the market for BSA
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 The flourishing in-vitro diagnostics industry in Germany is propelling the growth of BSA market
    • 11.3.2 UK
      • 11.3.2.1 The increase in rate of slaughter in cattle points to a growing market demand for BSA in the UK
    • 11.3.3 FRANCE
      • 11.3.3.1 The demand for functional foods from consumers could propel the growth of BSA in France
    • 11.3.4 SPAIN
      • 11.3.4.1 Reduced feed costs have led to an increased production in the country's livestock sector
    • 11.3.5 RUSSIA
      • 11.3.5.1 The need for reduction in the overall cost of feed to drive the market for BSA in Russia
    • 11.3.6 REST OF EUROPE
      • 11.3.6.1 The growth in demand for nutritional supplements and cost-effective ingredients to drive the market for BSA in the region
  • 11.4 ASIA PACIFIC
    • 11.4.1 CHINA
      • 11.4.1.1 Increase in R&D spending in the pharmaceutical industry for protein-based drug delivery to increase opportunities in China
    • 11.4.2 INDIA
      • 11.4.2.1 Increase in R&D on vaccines that use bovine serum albumin to provide market growth prospects in India
    • 11.4.3 JAPAN
      • 11.4.3.1 Demand for BSA nanoparticles to treat chronic diseases will provide new avenues for growth in Japan
    • 11.4.4 AUSTRALIA & NEW ZEALAND
      • 11.4.4.1 Demand for BSE-free bovine serum albumin offered by the Australia & New Zealand to drive growth
    • 11.4.5 REST OF ASIA PACIFIC
      • 11.4.5.1 Demand for protein-based drugs used to treat various diseases to propel market growth
  • 11.5 REST OF THE WORLD
    • 11.5.1 SOUTH AMERICA
      • 11.5.1.1 Increase in the production of cheese boosting the bovine serum albumin market in South America
    • 11.5.2 MIDDLE EAST & AFRICA
      • 11.5.2.1 Rise in demand for animal feed additives creating opportunities for the bovine serum albumin market in the Middle East & Africa

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
    • 12.2.1 TERMINOLOGY/NOMENCLATURE
      • 12.2.1.1 Visionary leaders
      • 12.2.1.2 Innovators
      • 12.2.1.3 Dynamic differentiators
      • 12.2.1.4 Emerging companies
  • 12.3 STRENGTH OF PRODUCT PORTFOLIO
  • 12.4 BUSINESS STRATEGY EXCELLENCE
  • 12.5 RANKING OF KEY PLAYERS, 2018
  • 12.6 COMPETITIVE SCENARIO
    • 12.6.1 NEW PRODUCT LAUNCHES
    • 12.6.2 EXPANSIONS & INVESTMENTS
    • 12.6.3 MERGERS & ACQUISITIONS

13 COMPANY PROFILES

(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*

  • 13.1 THERMO FISHER SCIENTIFIC INC.
  • 13.2 BIO-RAD LABORATORIES, INC.
  • 13.3 MERCK KGAA
  • 13.4 ITOHAM YONEKYU HOLDINGS INC.
  • 13.5 PROLIANT BIOLOGICALS
  • 13.6 KRAEBER & CO GMBH
  • 13.7 ROCKLAND IMMUNOCHEMICALS INC.
  • 13.8 ROCKY MOUNTAIN BIOLOGICALS
  • 13.9 BELHEALTH INVESTMENT PARTNERS, LLC
  • 13.10 BIO-TECHNE CORPORATION
  • 13.11 PROSPEC-TANY TECHNOGENE LTD.
  • 13.12 LGC GROUP
  • 13.13 PROMEGA CORPORATION
  • 13.14 BIOLOGICAL INDUSTRIES
  • 13.15 SERION GMBH

Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 AVAILABLE CUSTOMIZATIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
Back to Top